Supernus Pharmaceuticals (SUPN) Tax Rate (2011 - 2026)
Supernus Pharmaceuticals (SUPN) posted quarterly Tax Rate of 1.25% for Q2 2026, up 3372.0% year-over-year from 0.04% in Q2 2025, and up 98.92% on a QoQ basis from 115.99% in Q4 2025.
Supernus Pharmaceuticals (SUPN) Tax Rate (2011 - 2026) Analysis & Trends
Supernus Pharmaceuticals has reported Tax Rate for 13 years, with the latest figure at 1.25% in Q2 2026.
- Tax Rate for Q2 2026 came in at 1.25%, up 3372.0% year-over-year; the trailing twelve-month figure through Jun 2026 was 15.59% (down 585.0% YoY), and the FY2025 annual result was 21.37%, down 315.0% from the prior year.
- Tax Rate advanced to 1.25% in Q2 2026, from 115.99% in the prior quarter.
- Over five years, Tax Rate peaked at 495.5% in Q3 2022 and troughed at 115.99% in Q4 2025.
- A 5-year average of 36.86% and a median of 22.15% in 2025 frame the typical range for Tax Rate.
- The widest annual swing landed in 2022, when Tax Rate jumped 46995 bps; it then slumped 24756 bps in 2024.
- A 5-year view of Tax Rate shows it stood at 27.49% in 2022, then tumbled by 168 bps to 18.69% in 2023, then jumped by 323 bps to 41.71% in 2024, then tumbled by 378 bps to 115.99% in 2025, then soared by 99 bps to 1.25% in 2026.
- Per Business Quant data, the three most recent Tax Rate figures were 1.25% in Q2 2026, 115.99% in Q4 2025, and 22.15% in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Tax Rate (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 44.07 Bn | 43.10 Bn | - | - |
| 2 | Teva Pharmaceutical Industries | 43.42 Bn | 39.76 Bn | 2.15 Bn | -26.59% |
| 3 | Zoetis | 31.86 Bn | 30.18 Bn | 1.05 Bn | - |
| 4 | Takeda Pharmaceutical | 28.77 Bn | 22.98 Bn | 5.10 Bn | -30.40% |
| 5 | United Therapeutics | 22.29 Bn | 19.63 Bn | 683.80 Mn | 10.65% |
| 6 | Viatris | 18.78 Bn | 17.89 Bn | 1.46 Bn | -85.63% |
| 7 | Neurocrine Biosciences | 15.66 Bn | 15.27 Bn | 935.80 Mn | 10.97% |
| 8 | Elanco Animal Health | 11.91 Bn | 11.38 Bn | 798.00 Mn | 3.57% |
| 9 | Dr Reddys Laboratories | 10.16 Bn | 10.00 Bn | - | - |
| 10 | Supernus Pharmaceuticals | 2.77 Bn | 2.39 Bn | 185.39 Mn | -1.25% |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | -1.25% |
| Jun 30, 2026 | -1.25% |
| Jun 30, 2026 | -1.25% |
| Dec 31, 2025 | -114.47% |
| Dec 31, 2025 | -114.47% |
| Dec 31, 2025 | -114.47% |
| Sep 30, 2025 | 22.15% |
| Sep 30, 2025 | 22.15% |
| Sep 30, 2025 | 22.15% |
| Jun 30, 2025 | -34.98% |
| Jun 30, 2025 | -34.98% |
| Jun 30, 2025 | -34.98% |
| Mar 31, 2025 | -102.83% |
| Mar 31, 2025 | -102.83% |
| Mar 31, 2025 | -102.83% |
| Dec 31, 2024 | 41.90% |
| Dec 31, 2024 | 41.90% |
| Dec 31, 2024 | 41.90% |
| Sep 30, 2024 | 14.24% |
| Sep 30, 2024 | 14.24% |